Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?

J Rheumatol. 2011 Oct;38(10):2284. doi: 10.3899/jrheum.110170.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Eye Diseases / chemically induced*
  • Humans
  • Inflammation / chemically induced
  • Male
  • Receptors, Interleukin-6 / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Receptors, Interleukin-6
  • tocilizumab